ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Relmada Therapeutics Inc

Relmada Therapeutics Inc (RLMD)

0.3329
0.0043
(1.31%)
Closed 15 February 8:00AM
0.3303
-0.0026
( -0.78% )
Pre Market: 12:27AM

Relmada Therapeutics Inc Financial Summary

The current RLMD market cap is 9.97M. The company's latest EPS is USD -3.2741 and P/E is -0.10.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -22.69M-26.83M-22.99M-18.82M-23.01M
Net Income -22M-25.17M-21.83M-17.77M-21.73M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -8.27M-60.84M-125.7M-161.25M-103.7M
Net Income -8.2M-59.46M-125.75M-157.04M-98.79M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 109.15M97.55M84.41M71.03M55.73M
Total Liabilities 8.42M12.2M12.36M9.54M8.1M
Total Equity 100.73M85.36M72.05M61.49M47.63M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 117.14M118.19M223.33M152.91M97.55M
Total Liabilities 1.46M12.6M15.06M12.47M12.2M
Total Equity 115.68M105.58M208.27M140.44M85.36M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -41.41M-51.66M-13.04M-26.3M-42.96M
Investing 42.71M50.45M10.06M24.07M40.22M
Financing N/A -98k222k222k132k
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -6.41M-27.81M-91.87M-103.8M-51.66M
Investing -80.17M-34.45M-54.12M19.73M50.45M
Financing 113.64M28.47M187.94M45.02M-98k
Market Cap 9.97M
Price to Earnings Ratio -0.10
Price to Sales Ratio 0
Price to Cash Ratio 2.43
Price to Book Ratio 0.12
Dividend Yield -

Share Statistics

Shares Outstanding 30.17M
Average Volume (1 week) 1.04M
Average Volume (1 Month) 2.18M
52 Week Change -94.10%
52 Week High 7.2225
52 Week Low 0.28
Spread (Intraday) 0.02 (4.6%)

Company Info

Company Name Relmada Therapeutics Inc
Address 50 west liberty street suite 880
reno, nevada 89501
Website https://www.relmada.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock